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EDITORIAL
The effect of pancreas transplantation on
cardiovascular mortality
The uremic state is replete with multiple physiologic the method of insulin delivery into the circulation may
derangements that, taken together, contribute to the myr- be important. Kidney-pancreas transplants with systemic
iad presentations of vascular disease observed in end-stage (endocrine) venous drainage result in a state of eugly-
renal disease. Hyperphosphatemia, hyperparathyroidism, cemia at the expense of hyperinsulinemia similar to the
hyperhomocysteinemia, increased insulin resistance, and well-controlled insulin-dependent diabetic. Insulin resis-
other factors play a synergistic role in the unique patho- tance secondary to immunosuppressive agents and hyper-
physiology and epidemiology of vascular disease in renal insulinemia itself also contributes to spiraling levels of in-
disease [1]. sulin. Hyperinsulinemia has been linked to truncal obesity,
Despite amelioration of the uremic milieu in patients hypertension, and arteriosclerosis (syndrome X). Gaber
receiving a well-functioning kidney transplant, cardio- et al pioneered the portal-enteric pancreas transplant
vascular disease still accounts for more than 50% of graft where exocrine secretions were deposited enterically (in-
loss. More grafts succumb to cardiovascular disease than stead of bladder) and portal rather than systemic venous
immunologic loss, neoplasm, and infection combined [2]. drainage of endocrine hormones [7]. Because of the first-
A similar paradox exists in the well-controlled insulin- pass effect, portal drainage allows for euglycemia with-
dependent diabetic. Although an anti-atherogenic lipid out hyperinsulinemia. With perfection of this technique,
profile typically exists with exogenous insulin use [low previous complications of kidney-pancreas transplants
density lipoprotein (LDL), elevated high density lipopro- such as metabolic acidosis and dehydration were resolved.
tein (HDL), and rapid clearance of triglycerides], insulin- Stratta et al showed that the portal-enteric method of pan-
dependent diabetics have higher rates of coronary artery creas transplantation can be performed with equivalent
disease than the general population. The replacement of graft and patient survival rates to the systemic-bladder
feedback-regulated pancreatic beta cells by an intense technique [8].
regimen of insulin injections leads to a chronic hyperin- Secondary complications of diabetes, such as neuropa-
sulinemic state. Excess insulin, already known to be ath- thy and retinopathy, have been shown to be slowed by
erogenic by its capacity to act as a vascular smooth mus- tight glycemic control [9], but the effect of euglycemia on
cle growth factor, results in a deleterious alteration of cardiac function remains controversial. Normalization of
lipoprotein surface composition [3, 4]. diastolic and systolic cardiac function was reported in
Pancreas transplantation was conceptualized and even- kidney-pancreas (versus kidney alone) transplants at 24
tually developed with the expectation that a return to a months’ post-transplantation [10]. Unfortunately, a cor-
euglycemic state would halt or even reverse the clinical relation between these findings and reduction in cardio-
sequelae of long-standing type 1 diabetes. Pathologic evi- vascular mortality could not be concluded. Despite the
dence exists of early diabetic nephrology reversal in na- aforementioned discussion on the possible link of hyper-
tive kidneys after pancreas transplantation. Recurrence insulinemia to coronary artery disease (syndrome X),
of diabetic nephropathy in a functioning kidney-pancreas the data of La Rocca et al in this issue of Kidney Interna-
transplant is rare. Unfortunately, the question of whether tional are the first to establish a significant reduction in
cardiovascular mortality would be reduced by the addi- cardiovascular mortality when kidney/pancreas trans-
tion of a pancreas to a kidney transplantation remains plants are compared to kidney alone or patients re-
controversial. A worsening of the cardiovascular risk maining on the waiting list [11]. With obvious confound-
profile after pancreas transplantation has been suggested ers controlled, this study, with its relatively large sample
by some [5], but an improvement in risk factors have size, are the first to show that the cardiovascular mortal-
been found by others [6]. Some have hypothesized that ity of a pancreas transplant patient (even by the systemic-
bladder method) is reduced despite the theoretical con-
cerns and known complications of the procedure. TheKey words: high-density lipoprotein, vascular smooth muscle growth
factors, insulin, hyperinsulinemia, type 1 diabetes. importance of these conclusions cannot be understated
and should serve as the nidus for a large prospective 2001 by the International Society of Nephrology
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